Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qianghuo Guizhi Decoction is a Traditional Chinese Medicine (TCM) herbal formula primarily developed and studied by the Shanghai Municipal Hospital of Traditional Chinese Medicine. It is specifically indicated for postpartum rheumatism, a condition characterized by joint pain, numbness, and discomfort following childbirth, often attributed in TCM to the invasion of wind, cold, and dampness. The decoction's name is derived from its two key herbal components: Qianghuo (*Notopterygium incisum*), which is used to expel wind and dampness and alleviate pain, and Guizhi (*Cinnamomum cassia* twig), which serves to warm the meridians and improve circulation. The formula is typically administered as an oral liquid prepared by boiling the constituent herbs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qianghuo guizhi decoction.